Immunotherapy in HCC: Improving Outcomes Across the Disease Continuum

Learn more about the role of immunotherapy in intermediate HCC and learn from the experts on how to optimize treatment and outcomes through an on-demand webcast, downloadable slideset, and ClinicalThought commentary.

Share

Program Content

Activities

IO in Advanced HCC
Immunotherapy in Advanced/Metastatic HCC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 29, 2024

Expires: May 28, 2025

IO in Intermediate HCC
Immunotherapy-Based Combinations in Intermediate HCC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 29, 2024

Expires: May 28, 2025

IO in High-Risk Early HCC
Immunotherapy-Based Combinations as (Neo)Adjuvant Treatment in High-Risk HCC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 29, 2024

Expires: May 28, 2025

Activities

Hepatocellular Carcinoma at ASCO 2024
Immunotherapy in HCC: Improving Outcomes Across the Disease Continuum
Video
Congratulations: You achieved a completion on 04/09/2022

Released: June 17, 2024

Expires: June 16, 2025

Activities

FAQs: IO in HCC
Immunotherapy in the Management of Patients With HCC: Answers to Frequently Asked Questions
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: June 24, 2024

Expires: June 23, 2025

Faculty

cover img faculity

Richard S. Finn, MD

Professor
Department of Medicine
Division of Hematology/Oncology
UCLA David Geffen School of Medicine
Medical Director, Clinical Research Unit
Director, Signal Transduction and Therapeutics Program
University of California, Los Angeles
Los Angeles, California

cover img faculity

Sarah B. White, MD, MS, FSIR, FCIRSE

Professor of Radiology and Surgical Oncology
Vice Chair, Radiology Research
Associate Dean/Assistant Provost, Faculty Affairs
Senior Medical Director, Programmatic Excellence
Department of Radiology, Division of Vascular & Interventional Radiology
Medical College of Wisconsin
Milwaukee, Wisconsin

cover img faculity

Mark Yarchoan, MD

Associate Professor of Medical Oncology
Division of GI Malignancies
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University
Baltimore, Maryland

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca